Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Shares Outstanding (2022 - 2025)

Coya Therapeutics' Shares Outstanding history spans 4 years, with the latest figure at $16.7 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 9.99% year-over-year to $16.7 million; the TTM value through Sep 2025 reached $16.7 million, up 9.99%, while the annual FY2024 figure was $16.7 million, 15.98% up from the prior year.
  • Shares Outstanding for Q3 2025 was $16.7 million at Coya Therapeutics, roughly flat from $16.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $16.7 million in Q3 2025 and bottomed at $2.6 million in Q1 2022.
  • The 4-year median for Shares Outstanding is $14.4 million (2023), against an average of $11.8 million.
  • The largest annual shift saw Shares Outstanding soared 284.06% in 2023 before it increased 9.88% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $7.5 million in 2022, then soared by 92.05% to $14.4 million in 2023, then increased by 15.98% to $16.7 million in 2024, then increased by 0.21% to $16.7 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Shares Outstanding are $16.7 million (Q3 2025), $16.7 million (Q2 2025), and $16.7 million (Q1 2025).